AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 199 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $565,361 | +58.8% | 24,613 | +257.0% | 0.02% | -51.5% |
| Q1 2021 | $356,000 | -12.5% | 6,894 | -40.7% | 0.03% | +26.9% |
| Q3 2020 | $407,000 | -21.9% | 11,622 | +19.4% | 0.03% | -27.8% |
| Q2 2020 | $521,000 | -22.6% | 9,737 | -48.6% | 0.04% | -26.5% |
| Q1 2020 | $673,000 | -36.1% | 18,960 | -10.3% | 0.05% | -48.4% |
| Q2 2019 | $1,054,000 | +30.0% | 21,138 | +20.2% | 0.10% | +86.3% |
| Q4 2018 | $811,000 | +284.4% | 17,584 | +376.5% | 0.05% | +121.7% |
| Q4 2017 | $211,000 | – | 3,690 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
| Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
| Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
| Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
| Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
| ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
| AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
| PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |